View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AF43 Publication ID: Spring 2020 
Title: Sunscreen Drug Products For Over-The-Counter-Human Use; Final Monograph  
Abstract:

The final rule will describe the conditions of use under which OTC sunscreen products are generally recognized as safe and effective (GRASE) and not misbranded. Consistent with the Sunscreen Innovation Act, we expect that these conditions will include sunscreen dosage forms and the effectiveness of various SPF values.

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: Yes  Unfunded Mandates: Private Sector 
EO 13771 Designation: Regulatory 
CFR Citation: 21 CFR 201    21 CFR 310    21 CFR 347    21 CFR 352   
Legal Authority: 21 U.S.C. 321    21 U.S.C. 331    21 U.S.C. 351 to 353    21 U.S.C. 355    21 U.S.C. 360    21 U.S.C. 360ff-5    21 U.S.C. 371 to 374    21 U.S.C. 379e   
Legal Deadline:
Action Source Description Date
Final  Statutory  Sunscreen Innovation Act  11/26/2019 
Timetable:
Action Date FR Cite
ANPRM (Sunscreen and Insect Repellent)  02/22/2007  72 FR 7941   
ANPRM Comment Period End  05/23/2007    
NPRM (UVA/UVB)  08/27/2007  72 FR 49070   
NPRM Comment Period End  12/26/2007    
Final Action (UVA/UVB)  06/17/2011  76 FR 35620   
NPRM (Effectiveness)  06/17/2011  76 FR 35672   
NPRM (Effectiveness) Comment Period End   09/15/2011    
ANPRM (Dosage Forms)  06/17/2011  76 FR 35669   
ANPRM (Dosage Forms) Comment Period End  09/15/2011    
NPRM  02/26/2019  84 FR 6204   
NPRM Comment Period End  06/27/2019 
NPRM Extension of Comment Period  04/18/2019  84 FR 16222   
NPRM Extension of Comment Period End  06/27/2019 
Withdrawn  05/04/2020 
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: Local, State 
Small Entities Affected: Businesses  Federalism: Yes 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: Yes 
Related RINs: Split from 0910-AA01 
Agency Contact:
Trang Tran
Regulatory Project Manager
Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research, 10903 New Hampshire Avenue, WO 22, Room 4139,
Silver Spring , MD 20993
Phone:240 402-7945
Email: trang.tran@fda.hhs.gov